PTIX Protagenic: Accounting Value per Share
The book value per share of Protagenic Therapeutics (PTIX) reflects the dynamics of equity, while -2.44 characterizes this valuation parameter. A neutral geopolitical status in the US minimizes external risks. The business model relies on outsourcing production and testing to maintain flexibility. ESG principles are integrated into peptide development through strict bioethics and data security controls.
Protagenic Therapeutics Inc. - analytical breakdowns and key metrics (PTIX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:protagenic.com, PTIX
This indicator reflects the difference between total assets and liabilities, allowing investors to assess the real value of capital devoid of market speculation. Analyzing the book value per share helps identify hidden write-downs, which is particularly critical for Protagenic Therapeutics (PTIX), where conservative cash management and stable leadership minimize the risks of sudden liquidity loss.
Competitor analysis for Protagenic Therapeutics
Book Value per Share BIIB (Biogen Corp)|Neurocrine Corp (NBIX) - Net Assets per Share|Accounting Value per Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines PRAX|Share Book Value AVXL|CeriBell (CBLL) - Net Assets per Single Share|Accounting Value of a Share PRTA (Prothena Corporation)|ALEC: Net Assets per Single Share|ANNX - Net Asset Value per Share|Accounting Value per Share Omeros Corp. OMER|NGNE - Book Price of a Share|ACIU: Book Value per Share|Voyager Therapeutics Inc (VYGR) - Book Value per Share|Neumora Therapeutics Inc - Book Value per Share|Book Value of One Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share ACOG (alphacognition.com)|CGTX - Net Assets per Single Share|Equity per Share Inhibikase Therapeutics Inc IKT|Book Value per Share SAVA (Cassava)|ASRT - Net Assets per Share|COYA (coyatherapeutics.com) - Book Value per Share|Accounting Value per Share Vistagen|OVID - Accounting Value per Share|Accounting Value of a Share Acumen Pharmaceuticals Inc. (ABOS)|Accounting Value per Share CervoMed Inc|Book Price of a Share alteritytherapeutics.com (ATHE)|Book Value per Share Clene|Accounting Value of a Share PepGen Inc PEPG|JUNS (Jupiter Neurosciences Inc) - Book Value per Share|RLMD: Net Asset Value per Share|Net Assets per Single Share Annovis Bio Corp ANVS|Grace Therapeutics (GRCE) - Accounting Value of a Share|AIFF (Firefly Neuroscience, Inc) - Book Value per Share|Book Value per Share KLTO|NRSN - Net Assets per Single Share|Share Book Value Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Book Value per Share|NRXS - Net Asset Value per Share|Helius Medical Technologies Inc. - Accounting Value per Share|Passage Bio, Inc. (PASG) - Book Value per Share|NEUP - Accounting Value per Share|Minerva Neurosciences Inc (NERV) - Book Price of a Share|ATHA: Book Value per Share|Net Assets per Share Addex|Book Value per Share ALZN (Alzamend Neuro, Inc.)|Accounting Value per Share CYCN (cyclerion.com)|Net Assets per Single Share KTTA|Cortigent Inc - Net Assets per Share|Net Assets per Single Share Avenue Therapeutics, Inc|BrainStorm Cell Therapeutics Inc. (BCLI) - Share Book Value|CARA - Accounting Value per Share|chromocell.com (CHRO) - Book Price of a Share|ELYM: Book Value per Share|Net Assets per Share Intra-Cellular (ITCI)|Accounting Value per Share Longboard Pharma LBPH|Equity per Share MRNS (Marinus Pharma)|NKGN - Net Assets per Single Share|Equity per Share neurobopharma.com NRBO|SAGE (Sage Therapeutics) - Book Value per Share|Synaptogenix Inc. (SNPX) - Net Asset Value per Share|TRVN: Accounting Value per Share|VIGL (Vigil Neuroscience, Inc.) - Book Value per Share|WENA - Net Assets per Single Share|Accounting Value of a Share CERE